Pfizer has filed a lawsuit seeking to block Novo Nordisk from circumventing Pfizer's deal for weight-loss drug startup Metsera

Core Viewpoint - The lawsuit claims that Novo Nordisk's acquisition offer for drug startup Metsera is unlikely to be completed successfully [1] Group 1 - The lawsuit raises concerns about the feasibility of Novo Nordisk's offer for Metsera [1]